All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Treating elderly and frail patients with MM: Cure versus disease control

During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub hosted its first Satellite Symposium: Should 'cure' be the goal for multiple myeloma? Vincent Rajkumar, Mayo Clinic, Rochester, US, discussed: Treating elderly and frail patients with MM: Cure versus disease control.

The first Multiple Myeloma Hub Satellite Symposium: Should cure be the goal for multiple myeloma. Watch here!

Welcome to the Multiple Myeloma Hub Satellite Symposium.

Please take a moment to complete the survey and answer the following question to help us gauge your current understanding of the treatment of multiple myeloma.

In this presentation, Rajkumar discusses the current standard of treatment for elderly, frail patients (VRd−bortezomib, lenalidomide, dexamethasone) and regimens that are currently being tested across various clinical trials to improve upon this standard, such as replacement of bortezomib with carfilzomib or daratumumab, and quadruplet combinations. He then discusses if a cure is really feasible for MM, and highlights some key considerations for a true cure; when treatment is given for a finite time and the disease never returns. He concludes with his recommendations for assessing MM cure in future trials.

Treating elderly and frail patients with MM: Cure versus disease control

Vincent Rajkumar's slides are available as a downloadable resource below.

Download the slides here!

Find below links to the other talks from the symposium:

'Does 'cure' have a different meaning in MM?' presented by Mohamad Mohty.  

'Is the treatment of high-risk smoldering multiple myeloma (SMM) the way for achieving the cure?' presented by María-Victoria Mateos. 

'Is transplantation still relevant? If yes, in which context?' presented by Sagar Lonial.

'Roundtable discussion' with María-Victoria Mateos, Mohamad Mohty, and Sagar Lonial.